readthroughSign in
CompanyALKSNasdaqDublin 4, L2

Alkermes, Inc.

Alkermes develops neuroscience medicines including commercial products for alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder, and narcolepsy.

8-KNov 12Latest SEC filing
Nov 12Latest story